Granulocyte colony‐stimulating factor may improve engraftment in adults with sickle cell disease undergoing non‐myeloablative haematopoietic stem cell transplantation

Documenti analoghi

• High dose total marrow irradiation (TMI) does not increase long‐term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT)
  di: Lucas Maahs, et al.
  Pubblicazione: (2024)
• Alkaline phosphatase as a marker for painful vaso‐occlusive events and other acute complications in sickle cell disease
  di: Jin Han, et al.
  Pubblicazione: (2024)
• Comprehensive risk stratification for adult T‐cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation
  di: Fangfang Yu, et al.
  Pubblicazione: (2025)
• Impact of voxelotor discontinuation on patients with sickle cell disease
  di: Jin Han, et al.
  Pubblicazione: (2026)
• Utility of transplant conditioning intensity score in allogeneic haematopoietic stem cell transplantation for genetic disorders
  di: Koji Kawaguchi, et al.
  Pubblicazione: (2026)